Indication
Erythema nodosum leprosum
Erythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy. Read more about Erythema nodosum leprosum
3 drugs 3 manufacturers
Drugs that treat it
Common Erythema nodosum leprosum therapies.
THALOMID (thalidomide)
LAMPRENE (clofazimine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonErythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy.
It affects the integumentary and nervous systems as well as multiple visceral organs, driven immunologically by circulating immune complex deposition, intense neutrophil infiltration, and systemic release of pro-inflammatory cytokines such as tumor necrosis factor-alpha.
Clinically, it presents with painful, tender crops of erythematous subcutaneous nodules or plaques frequently accompanied by high fever, malaise, peripheral neuritis, arthralgias, lymphadenopathy, and potentially organ-threatening complications such as iridocyclitis or orchitis.
- nih.gov
Erythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy Clinically, it presents with painful, tender crops of erythematous subcutaneous nodules or plaques frequently accompanied by high fever, malaise, peripheral neuritis, arthralgias, lymphadenopathy, and potentially organ-threatening complic...
- nih.gov
Erythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy It affects the integumentary and nervous systems as well as multiple visceral organs, driven immunologically by circulating immune complex deposition, intense neutrophil infiltration, and systemic release of pro-inflammatory cytokines suc...
- leprosy-information.org
It affects the integumentary and nervous systems as well as multiple visceral organs, driven immunologically by circulating immune complex deposition, intense neutrophil infiltration, and systemic release of pro-inflammatory cytokines such as tumor necrosis factor-alpha Clinically, it presents with painful, tender crops of erythematous subcutaneous nodules or plaques frequently accompanied by high fever, malaise, peripheral neuritis, arthralgias, lymphadenopathy, and potentially organ-threatenin...
- frontiersin.org
Clinically, it presents with painful, tender crops of erythematous subcutaneous nodules or plaques frequently accompanied by high fever, malaise, peripheral neuritis, arthralgias, lymphadenopathy, and potentially organ-threatening complications such as iridocyclitis or orchitis
Personalize your experience
Follow Erythema nodosum leprosum and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.